graft rejection

临床试验

计划入组 44 人 · 首次发布于 2012 年 9 月 28 日

已完成

NCT06281587

Pathogenetic Risk Factors for Corneal Graft Rejection

计划入组 93 人 · 首次发布于 2024 年 2 月 28 日

招募中

NCT07275541

Platelet Aggregation in the Diagnosis of Acute Graft Rejection

计划入组 60 人 · 首次发布于 2025 年 12 月 10 日

药物

查看全部 102 →

Small Molecule

Approved

Thiotepa(Tepadina, Thiotepa Riemser)

相关疾病：Adenocarcinoma of the Ovaries, Breast Adenocarcinoma，另有 2 项

C₆H₁₂N₃PS · Rx

ReliDerm DT

Graft vs. Host Disease(Aegle)

机构

查看全部 10 →

Vascular Graft Solutions Ltd.

Israel

Paragon 28

United States

InspireMD

资讯

查看全部 2398 →

上个月

Allogenetics Appoints Dr. Jeroen Rovers as Chief Medical Officer to Advance ALG-115 Toward Clinical Trials in Lung Transplantation

7天前

Allogenetics Raises €3.8M Pre-Series A to Advance Ex Vivo Gene Therapy for Rejection-Resistant Donor Lungs

3个月前

临床试验

Neovascularization Patterns in Corneal Graft Rejection

Pathogenetic Risk Factors for Corneal Graft Rejection

Platelet Aggregation in the Diagnosis of Acute Graft Rejection

药物

Thiotepa(Tepadina, Thiotepa Riemser)

ReliDerm DT

Graft vs. Host Disease(Aegle)

机构

Vascular Graft Solutions Ltd.

Paragon 28

InspireMD

资讯

Allogenetics Appoints Dr. Jeroen Rovers as Chief Medical Officer to Advance ALG-115 Toward Clinical Trials in Lung Transplantation

Allogenetics Raises €3.8M Pre-Series A to Advance Ex Vivo Gene Therapy for Rejection-Resistant Donor Lungs

Biomarker-Guided Immunosuppression Shows Safety in Kidney Transplant: TTVguideIT Phase II Trial Meets Primary Endpoint